Which management department of the pharmaceutical company (

State administration of medical products. Acarbose tablets, an oral hypoglycemic drug of Kanglian Group, was officially approved for marketing by the State Administration of Pharmaceutical Products. Acarbose tablet is an oral hypoglycemic agent, which belongs to the category of α -glucosidase inhibitors and has been included in the national medical insurance catalogue, and is mainly used to treat type II diabetes. The target population is patients with pre-diabetes symptoms who need early treatment, and patients with postprandial hyperglycemia whose condition is under control.